The receptor for advanced glycation end product (RAGE) pathway in COVID-19

References

• Bianchi, M.E., 2007. DAMPs, PAMPs and Alarmins: All We Need to Know About Danger. Journal of leukocyte biology, 81 (1), 1–5.
   PubMed Web of Science ®Google Scholar
• Bierhaus, A., et al., 2005. Understanding RAGE, the receptor for advanced glycation end products. Journal of molecular medicine (Berlin, Germany), 83 (11), 876–886.
   PubMed Web of Science ®Google Scholar
• Blondonnet, R., et al., 2017. RAGE inhibition reduces acute lung injury in mice. Scientific reports, 7 (1), 7208.
   PubMed Web of Science ®Google Scholar
• Brojakowska, A., et al., 2020. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System. Journal of the American College of Cardiology, 75 (24), 3085–35004.
   PubMed Web of Science ®Google Scholar
• Calfee, C.S., et al.,; NHLBI ARDS Network. 2008. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax journal, 63 (12), 1083–1089.
   PubMed Web of Science ®Google Scholar
• Chen, N., et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (london, England), 395 (10223), 507–513.
   PubMed Web of Science ®Google Scholar
• Ekong, U., et al., 2006. Blockade of the Receptor for Advanced Glycation End Products Attenuates Acetaminophen-Induced Hepatotoxicity in Mice. Journal of gastroenterology and hepatology, 21 (4), 682–688.
   PubMed Web of Science ®Google Scholar
• Falcone, C., et al., 2005. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arteriosclerosis, thrombosis, and vascular biology, 25 (5), 1032–1037.
   PubMed Web of Science ®Google Scholar
• Forbes, J.M., et al., 2005. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol, 16 (8), 2363–2372.
   PubMed Web of Science ®Google Scholar
• Franceschi, C., et al., 2017. Inflammaging and 'Garb-aging'. Trends in endocrinology and metabolism: tem, 28 (3), 199–212.
   PubMed Web of Science ®Google Scholar
• Frimat, M., Teissier, T., and Boulanger, E., 2019. Is RAGE the receptor for inflammaging? Aging, 11 (17), 6620–6621.
   PubMedGoogle Scholar
• Geroldi, D., et al., 2005. Decreased plasma levels of soluble receptor for advanced glycation end‐products in patients with essential hypertension. Journal of hypertension, 23 (9), 1725–1729.
   PubMed Web of Science ®Google Scholar
• Hallam, K.M., et al., 2010. Aldose Reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats. Aging cell, 9 (5), 776–784.
   PubMed Web of Science ®Google Scholar
• Hofmann, M.A., et al., 2002. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and immunity, 3 (3), 123–135.
   PubMed Web of Science ®Google Scholar
• Huttunen, H.J., et al., 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. Cancer research and treatment, 62 (28), 4805–4811.
   Google Scholar
• Jabaudon, M., et al., 2015. Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. American journal of respiratory and critical care medicine, 192 (2), 191–199.
   PubMed Web of Science ®Google Scholar
• Janeway, C.A., and Medzhitov, R., 2002. Innate immune recognition. Annual review of immunology, 20 (17), 197–216.
   PubMed Web of Science ®Google Scholar
• Kuba, K., Imai, Y., and Penninger, J.M., 2006. Angiotensin-converting enzyme 2 in lung diseases. Current opinion in pharmacology, 6 (3), 271–276.
   PubMed Web of Science ®Google Scholar
• Morbini, P., et al., 2006. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Modern pathology : an official journal of the united states and canadian academy of pathology, inc, 19 (11), 1437–1445.
   PubMed Web of Science ®Google Scholar
• Nakamura, T., et al., 2011. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clinical biochemistry, 44 (8-9), 601–604.
   PubMed Web of Science ®Google Scholar
• Neeper, M., et al., 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Journal of biological chemistry, 267 (21), 14998–15004.
   PubMed Web of Science ®Google Scholar
• Oczypok, E.A., Perkins, T.N., and Oury, T.D., 2017. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Paediatric respiratory reviews, 23, 40–49.
   PubMed Web of Science ®Google Scholar
• Reynolds, P.R., et al., 2010. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. American journal of respiratory cell and molecular biology, 42 (5), 545–551.
   PubMed Web of Science ®Google Scholar
• Teissier, T., and Boulanger, É., 2019. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging. Biogerontology, 20 (3), 279–301.
   PubMed Web of Science ®Google Scholar
• Vistoli, G., et al., 2013. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free radical research, 47 (sup1), 3–27.
   PubMed Web of Science ®Google Scholar
• Wang, X., and Ding, Y.Q., 2020. [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 49 (6), 647–652.
   PubMedGoogle Scholar
• Yan, R., et al., 2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (New York, N.Y.).), 367 (6485), 1444–1448.
   PubMed Web of Science ®Google Scholar
• Yeh, C.H., et al., 2001. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes journal, 50 (6), 1495–1504.
   PubMed Web of Science ®Google Scholar
• Yin Wong, L.S., et al., 2020. Age-Related differences in immunological responses to SARS-CoV-2. The journal of allergy and clinical immunology, 27 (20), 30842–33044.
   Google Scholar
• Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The lancet, 395 (10229), 1054–1062.
   PubMed Web of Science ®Google Scholar